G William Letson
Overview
Explore the profile of G William Letson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Letson G, Marfin A, Mooney J, Minh H, Hills S
PLoS Negl Trop Dis
. 2024 Sep;
18(9):e0012390.
PMID: 39226312
Background: Japanese encephalitis (JE) virus is the leading cause of vaccine-preventable encephalitis and a significant cause of disability in Asia and the western Pacific. Many countries have introduced JE vaccination...
2.
Sultana R, Slavkovsky R, Ullah M, Tasnim Z, Sultana S, Khan S, et al.
Emerg Infect Dis
. 2023 Nov;
29(12):2488-2497.
PMID: 37987586
Japanese encephalitis (JE) is associated with an immense social and economic burden. Published cost-of-illness data come primarily from decades-old studies. To determine the cost of care for patients with acute...
3.
Nguyen A, Slavkovsky R, Phan H, Nguyen H, Vannachone S, Le D, et al.
PLOS Glob Public Health
. 2023 Jun;
3(6):e0001873.
PMID: 37310946
Background: Japanese encephalitis (JE) is a leading cause of acute encephalitis syndrome and resulting neurological disability in Asia and the Western Pacific. This study aims to estimate the cost of...
4.
Kosen S, Khoe L, Indriasih E, Tarigan I, Iriawan R, Agustiya R, et al.
Vaccine X
. 2022 Jul;
11:100179.
PMID: 35782720
Introduction: A Markov model was used to evaluate the potential health and economic impact of introducing JE vaccine nationally and in selected endemic areas of Indonesia compared to no vaccination...
5.
Zaman K, Yunus M, Aziz A, Feser J, Mooney J, Tang Y, et al.
Vaccine X
. 2022 Mar;
10:100143.
PMID: 35243320
Introduction: Japanese encephalitis (JE) virus is one of the leading causes of viral encephalitis across temperate and tropical zones of Asia. The live attenuated SA 14-14-2 JE vaccine (CD-JEV) is...
6.
Vannice K, Hills S, Schwartz L, Barrett A, Heffelfinger J, Hombach J, et al.
NPJ Vaccines
. 2021 Jun;
6(1):82.
PMID: 34131150
No abstract available.
7.
Hills S, Van Keulen A, Feser J, Panella A, Letson G, Staples J, et al.
Am J Trop Med Hyg
. 2020 Nov;
104(2):576-579.
PMID: 33236716
Japanese encephalitis (JE) is a vaccine-preventable, mosquito-borne disease. Substantial progress with JE control in Asia has been made during the past decade, with most endemic countries now having JE vaccination...
8.
Capeding M, Alberto E, Feser J, Mooney J, Tang Y, Audet S, et al.
Vaccine X
. 2020 Oct;
6:100074.
PMID: 33005887
Introduction: Japanese encephalitis (JE) virus is the leading cause of viral encephalitis across temperate and tropical zones of Asia. The live attenuated SA 14-14-2 JE vaccine (CD-JEV) is one of...
9.
Wangchuk S, Tamang T, Darnal J, Pelden S, Lhazeen K, Mynak M, et al.
Emerg Infect Dis
. 2020 Aug;
26(9):2239-2242.
PMID: 32818416
In 2011, Bhutan's Royal Centre for Disease Control began Japanese encephalitis (JE) surveillance at 5 sentinel hospitals throughout Bhutan. During 2011-2018, a total of 20 JE cases were detected, indicating...
10.
Groman D, Higgins D, Khan S, Simpson E, Pecenka C, Newhouse L, et al.
Gates Open Res
. 2020 Feb;
3:1544.
PMID: 32025632
In an increasingly crowded vaccine landscape, global and country decision-makers will require evidence-based and disease-specific information when prioritizing new public health interventions. The Advancing Maternal Immunization collaboration (AMI) was designed...